DRD2 and autoimmune encephalitis: Significant clinical improvement was observed, and by the 18th day of admission, the patient was stable and coherent.<h4>Conclusions</h4>The current patient represents the first reported case of double-positive autoimmune encephalitis for anti-D2R and DPPX antibodies, with epilepsy as a prominent feature.